Efficacy of checkpoint inhibitors in genitourinary cancers with advanced chronic kidney disease
{{output}}
Background: Immunological checkpoint inhibitors (ICIs) have shown promise in treating various malignancies but are understudied in genitourinary cancers among patients with advanced chronic kidney disease (CKD), who are typically... ...
